CAMILLA EVANGELISTI
- Type
- Persona (Classe)
- Label
- CAMILLA EVANGELISTI (literal)
- CAMILLA EVANGELISTI (literal)
- Persona in rapporto
- Rapporto con CNR di DOTT. CAMILLA EVANGELISTI (Rapporto con CNR)
- Autore CNR di
- Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Advances in targeting signal transduction pathways. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; Indications for novel therapeutics (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Current treatment strategies for inhibiting mTOR in cancer (Articolo in rivista) (Prodotto della ricerca)
- Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mtor cascades which alter therapy response (Articolo in rivista) (Prodotto della ricerca)
- Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance. (Articolo in rivista) (Prodotto della ricerca)
- Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered lamins (Articolo in rivista) (Prodotto della ricerca)
- Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies. (Articolo in rivista) (Prodotto della ricerca)
- The emerging multiple roles of nuclear Akt. (Articolo in rivista) (Prodotto della ricerca)
- Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: Targeting the unfolded protein response signaling (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review) (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Autophagy in acute leukemias: A double-edged sword with important therapeutic implications (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Coautore
- GIOVANNA LATTANZI (Unità di personale interno)
- Alberto Maria Martelli (Unità di personale esterno)
- Francesca Chiarini (Persona)
- STEFANO SQUARZONI (Persona)
- MELCHIORRE CERVELLO (Persona)
- FRANCESCA CHIARINI (Persona)
- Nome
- CAMILLA (literal)
- Cognome
- EVANGELISTI (literal)
- Afferisce a
- Institute of molecular genetics (IGM) (Istituto)
Incoming links:
- Ha afferente
- Institute of molecular genetics (IGM) (Istituto)
- Coautore
- MELCHIORRE CERVELLO (Persona)
- GIOVANNA LATTANZI (Unità di personale interno)
- STEFANO SQUARZONI (Persona)
- Francesca Chiarini (Persona)
- Alberto Maria Martelli (Unità di personale esterno)
- FRANCESCA CHIARINI (Persona)
- http://www.cnr.it/ontology/cnr/individuo/unitaDiPersonaleEsterno/ID25223
- Rapporto con persona
- Rapporto con CNR di DOTT. CAMILLA EVANGELISTI (Rapporto con CNR)
- Autore CNR
- Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies. (Articolo in rivista) (Prodotto della ricerca)
- The emerging multiple roles of nuclear Akt. (Articolo in rivista) (Prodotto della ricerca)
- Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance. (Articolo in rivista) (Prodotto della ricerca)
- Advances in targeting signal transduction pathways. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; Indications for novel therapeutics (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: Targeting the unfolded protein response signaling (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review) (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Autophagy in acute leukemias: A double-edged sword with important therapeutic implications (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Current treatment strategies for inhibiting mTOR in cancer (Articolo in rivista) (Prodotto della ricerca)
- Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mtor cascades which alter therapy response (Articolo in rivista) (Prodotto della ricerca)
- Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered lamins (Articolo in rivista) (Prodotto della ricerca)